Recent progress on nanomedicine-induced ferroptosis for cancer therapy

• Published in: Biomaterials science 2021-08, Vol.9 (15), p.592-5115
• Main Authors: Zafar, Hajra, Raza, Faisal, Ma, Siyu, Wei, Yawen, Zhang, Jun, Shen, Qi
• Format: Article
• Language: English
• Subjects: Cancer therapies; Cell death; Therapy; Tumors
• ISSN: 2047-4830; 2047-4849
• DOI: 10.1039/d1bm00721a

The current treatment strategies for cancer therapy have posed many problems in achieving high efficacy. Therefore, an urgent step is needed to develop innovative therapies that can win beyond satisfactory results against tumor. Ferroptosis that is a kind of non-apoptotic based programmed cell death has played a crucial role in eradicating tumors by reactive oxygen species and iron-dependent pathways. Research shows a remarkable potential of ferroptosis in eliminating aggressive malignancies resistant to traditional therapies. The combination of nanomedicine and ferroptosis has revealed a close relationship for the treatment of various cancer types with high efficacy. This review introduces the basics of nanomedicine-based ferroptosis first to emphasize the feasibility and properties of ferroptosis in cancer therapy. Then, the current research on the applications of nanomedicine for the ferroptosis-based anticancer therapy is highlighted. Finally, conclusions and future research directions in perspective of various challenges in developing nanomedicine-based ferroptosis into clinical therapeutics are discussed. The basics of nanomedicine-based ferroptosis are summarized. The applications and future research directions of nanomedicine for ferroptosis-based anticancer therapy are presented.